|
1-888-891-4385 Studies from University of Connecticut provide new data on alcoholism"Glutamate neurotransmission plays an important role in a variety of alcohol-related phenomena, including Alcohol self-administration by both animals and humans. Because the risk for Alcohol dependence (AD) is genetically influenced, genes encoding glutamate receptors are candidates to contribute to the risk for AD," researchers in the United States report (see also Alcoholism). "We examined the role of variation in the 3' region of GRIK1, the gene that encodes the GluR5 receptor subunit of the kainic acid glutamate receptor, on risk for AD. We focused specifically on this gene because topiramate, a glutamate modulator that binds to the GluR5 subunit, has shown robust efficacy in the treatment of AD. We genotyped 7 single nucleotide polymorphisms (SNPs) in the 3'-half of GRIK1, which includes 3 differentially spliced exons, in a sample of EA control subjects (n = 507) and subjects with AD (n = 1,057). We found nominally significant evidence of association to AD for 3 SNPs (rs2832407 in intron 9, rs2186305 in intron 17, and rs2832387 in the 3'UTR). Empirical p-value estimation revealed that only rs2832407 was significantly associated to phenotype (p = 0.043). These findings provide support for the hypothesis that variation in the 3' portion of the gene encoding the GluR5 kainate receptor subunit contributes to the risk for AD," wrote H.R. Kranzler and colleagues, University of Connecticut. The researchers concluded: "Further research is needed to ascertain whether this SNP is itself functional or whether the association reflects linkage disequilibrium with functional variation elsewhere in the gene and whether this SNP moderates topiramate's effects in the treatment of AD." Kranzler and colleagues published their study in Alcoholism - Clinical and Experimental Research (Association of Markers in the 3' Region of the GluR5 Kainate Receptor Subunit Gene to Alcohol Dependence. Alcoholism - Clinical and Experimental Research, 2009;33(5):925-930). For additional information, contact H.R. Kranzler, University of Connecticut, Center Health, Dept. of Psychiatry, Farmington, CT 06030, USA. |
Cities in Connecticut : Bridgeport New Haven Hartford Stamford Waterbury Norwalk Danbury New Britain West Hartford Bristol Meriden West Haven Milford Stratford East Hartford Middletown Shelton Norwich Torrington Trumbull Naugatuck Central Manchester Newington East Haven Wethersfield Westport New London North Haven Darien Ansonia Wallingford Center Willimantic Orange Derby Windsor Locks Storrs Conning Towers-Nautilus Park Groton Bethel Oakville Kensington Thompsonville Southwood Acres Rockville Winsted Ridgefield Glastonbury Center Putnam District New Milford Cheshire Village Branford Center Sherwood Manor Simsbury Center Portland Pawcatuck Terryville Hazardville Danielson Mystic Long Hill Clinton Broad Brook Heritage Village Northwest Harwinton Moosup Old Mystic Lake Pocotopaug Niantic Jewett City Blue Hills Oxoboxo River Central Waterford Coventry Lake Weatogue Durham Collinsville Plainfield Village Guilford Center Essex Village Deep River Center Salmon Brook West Simsbury East Hampton Westbrook Center Madison Center Bethlehem Village Old Saybrook Center Newtown Noank North Granby Woodmont Higganum Georgetown Central Somers Poquonock Bridge Canton Valley Chester Center East Brooklyn Crystal Lake North Grosvenor Dale South Coventry Tariffville Litchfield Woodbury Center Canaan South Windham Moodus Suffield Depot South Woodstock Saybrook Manor Quinebaug New Preston Wauregan New Hartford Center Terramuggus Stonington Mansfield Center Bantam Groton Long Point Fenwick |